InvestorsHub Logo

Hoskuld

04/02/23 1:22 PM

#409589 RE: attilathehunt #409587

The ATM will be exercised when in makes sense - at higher share prices. Anavex's annual dilution is absolutely minimal compared to peers.

Investor2014

04/03/23 12:45 AM

#409622 RE: attilathehunt #409587

The first thought an Anavex investor might have with that LPC agreement was announced, would be that the company prepares for running a P3 Precision Medicine trial as the outcome of the P2b/3 trial.

I am confident all OBJECTIVES where met for such a trial to be well designed. Anavex is just having a bit of communications confusion over the difference between meeting endpoints and their own objectives.